Chengdu Kanghong Pharmaceuticals Group Co Ltd Net Asset Quality Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd net asset quality index. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Net Asset Quality Index of 92.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥9.94 Billion minus total liabilities of CN¥758.30 Million yields net assets of CN¥9.18 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Chengdu Kanghong Pharmaceuticals Group C shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Net asset quality index of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. This chart shows how Chengdu Kanghong Pharmaceuticals Group Co Ltd's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the index stands at 92.4%, representing net assets of CN¥9.18 Billion against total assets of CN¥9.94 Billion CNY. Check Chengdu Kanghong Pharmaceuticals Group C PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Net Asset Quality Index by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd net asset quality index by year from 2009 to 2025. The table below presents the year-by-year Net Asset Quality Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Chengdu Kanghong Pharmaceuticals Group C.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.5% | CN¥9.27 Billion | CN¥9.92 Billion | CN¥645.22 Million | ▲ +0.9 pp |
| 2024 | 92.6% | CN¥8.65 Billion | CN¥9.34 Billion | CN¥695.07 Million | ▲ +1.0 pp |
| 2023 | 91.6% | CN¥7.81 Billion | CN¥8.53 Billion | CN¥717.76 Million | ▲ +2.1 pp |
| 2022 | 89.5% | CN¥6.91 Billion | CN¥7.72 Billion | CN¥813.85 Million | ▲ +1.7 pp |
| 2021 | 87.8% | CN¥6.10 Billion | CN¥6.96 Billion | CN¥851.08 Million | ▲ +5.6 pp |
| 2020 | 82.2% | CN¥5.76 Billion | CN¥7.00 Billion | CN¥1.25 Billion | ▲ +2.9 pp |
| 2019 | 79.3% | CN¥4.62 Billion | CN¥5.83 Billion | CN¥1.21 Billion | ▲ +0.7 pp |
| 2018 | 78.6% | CN¥4.08 Billion | CN¥5.19 Billion | CN¥1.11 Billion | ▲ +1.4 pp |
| 2017 | 77.3% | CN¥3.54 Billion | CN¥4.59 Billion | CN¥1.04 Billion | ▼ 0.0 pp |
| 2016 | 77.3% | CN¥2.90 Billion | CN¥3.76 Billion | CN¥853.27 Million | ▼ -9.7 pp |
| 2015 | 87.0% | CN¥2.52 Billion | CN¥2.90 Billion | CN¥376.19 Million | ▲ +4.0 pp |
| 2014 | 83.0% | CN¥1.61 Billion | CN¥1.94 Billion | CN¥329.11 Million | ▲ +1.1 pp |
| 2013 | 82.0% | CN¥1.39 Billion | CN¥1.69 Billion | CN¥305.69 Million | ▲ +7.3 pp |
| 2012 | 74.7% | CN¥1.11 Billion | CN¥1.48 Billion | CN¥375.39 Million | ▲ +2.4 pp |
| 2011 | 72.3% | CN¥936.39 Million | CN¥1.30 Billion | CN¥359.58 Million | ▲ +9.2 pp |
| 2010 | 63.0% | CN¥624.85 Million | CN¥991.06 Million | CN¥366.21 Million | ▼ -2.5 pp |
| 2009 | 65.5% | CN¥539.75 Million | CN¥823.48 Million | CN¥283.73 Million | — |